
    
      In this study, the investigators are investigating the effects of InnoSlimÂ® on blood sugar
      and blood lipids regulation in humans. The testing sample is orally administrated to
      participants with pre-diabetes and hyperlipidemia humans, the efficacy parameters of blood
      sugar, lipid profile and other parameters, as well as adverse effects to the healthy
      individual, are screened during the trial, the significant difference is shown and no adverse
      effect reported.
    
  